Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06595836

Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom

Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom (Phase II Slippage/Breakage Study)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Thai Nippon Rubber Industry Public Company Limited · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study is a masked (investigators, research staff), two-way crossover, randomized to sequence of use study designed to evaluate the acceptability and functional performance (breakage, slippage) of a silicone lubricated polyisoprene condom and a silicone lubricated natural rubber latex condom.

Detailed description

Three hundred (300) couples will be enrolled and asked to use five condoms of each of the two types of lubricated condoms to yield a potential sample size of 1500 uses for each type of lubricated condom. To minimize a potential learning effect, couples will be randomly assigned to the sequence of use of each type of lubricated condom. The primary objective of this study is to examine the slippage, breakage and acceptability of a new polyisoprene male condom compared to a natural rubber latex condom. The study will assess safety in terms of adverse events and user acceptability will be evaluated by comparing physical attributes of the polyisoprene and latex control condoms, as well as perceptions about using the devices.

Conditions

Interventions

TypeNameDescription
DEVICESilicone Lubricated Synthetic polyisoprine condomSynthetic polyisoprene condom are made from softer materials for a more natural feel and increased sensitivity
DEVICESilicone Lubricated Natural Rubber Latex CondomNatural rubber latex condoms are made from natural rubber

Timeline

Start date
2024-01-02
Primary completion
2024-12-31
Completion
2025-02-28
First posted
2024-09-19
Last updated
2024-09-19

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06595836. Inclusion in this directory is not an endorsement.